Skip to main content

Laser-Based Bioprinter

Objective

Bioprinting is a rapidly developing technology sector aimed at additive manufacturing of tissues and organs. It is expected to lead to the most disruptive biomedical applications of additive manufacturing. Apart from tissue engineering and regenerative medicine, bioprinting applications of immediate commercial and societal benefit include the development of personalized cancer therapies and realization of in vitro tissue models based on human biology for reliable drug tests in pharma industry. The latter one is especially attractive, as it will potentially result in substantial savings of drug development costs. Furthermore, it may help to considerably reduce the need for animal studies in the foreseeable future. The need for increased resolution is one of the main technological challenges of bioprinting today. Most currently available bioprinters are based on dispensing methods. Therefore, the achievable spatial resolution is in the range of tens of micrometers. The possibility to reproduce features on the submicrometer scale would provide the missing link to accessing the complexity of natural cell environment and enable fabrication of truly biomimetic constructs.

Field of science

  • /medical and health sciences/medical biotechnology/tissue engineering
  • /engineering and technology/mechanical engineering/manufacturing engineering/additive manufacturing
  • /medical and health sciences/clinical medicine/oncology/cancer

Call for proposal

ERC-2015-PoC
See other projects for this call

Funding Scheme

ERC-POC - Proof of Concept Grant

Host institution

TECHNISCHE UNIVERSITAET WIEN
Address
Karlsplatz 13
1040 Wien
Austria
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 149 850

Beneficiaries (1)

TECHNISCHE UNIVERSITAET WIEN
Austria
EU contribution
€ 149 850
Address
Karlsplatz 13
1040 Wien
Activity type
Higher or Secondary Education Establishments